Neurogene (NGNE) Operating Income: 2018-2025
Historic Operating Income for Neurogene (NGNE) over the last 4 years, with Sep 2025 value amounting to -$23.8 million.
- Neurogene's Operating Income fell 7.29% to -$23.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$97.3 million, marking a year-over-year decrease of 28.33%. This contributed to the annual value of -$82.6 million for FY2024, which is 48.62% down from last year.
- As of Q3 2025, Neurogene's Operating Income stood at -$23.8 million, which was up 8.75% from -$26.1 million recorded in Q2 2025.
- In the past 5 years, Neurogene's Operating Income registered a high of -$12.6 million during Q2 2023, and its lowest value of -$26.1 million during Q2 2025.
- In the last 3 years, Neurogene's Operating Income had a median value of -$20.1 million in 2024 and averaged -$19.5 million.
- Data for Neurogene's Operating Income shows a maximum YoY plummeted of 59.84% (in 2024) over the last 5 years.
- Quarterly analysis of 3 years shows Neurogene's Operating Income stood at -$14.7 million in 2023, then slumped by 46.01% to -$21.5 million in 2024, then dropped by 7.29% to -$23.8 million in 2025.
- Its last three reported values are -$23.8 million in Q3 2025, -$26.1 million for Q2 2025, and -$25.9 million during Q1 2025.